These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
255 related articles for article (PubMed ID: 31268670)
1. Nanoparticle-Aided Characterization of Arterial Endothelial Architecture during Atherosclerosis Progression and Metabolic Therapy. Beldman TJ; Malinova TS; Desclos E; Grootemaat AE; Misiak ALS; van der Velden S; van Roomen CPAA; Beckers L; van Veen HA; Krawczyk PM; Hoebe RA; Sluimer JC; Neele AE; de Winther MPJ; van der Wel NN; Lutgens E; Mulder WJM; Huveneers S; Kluza E ACS Nano; 2019 Dec; 13(12):13759-13774. PubMed ID: 31268670 [TBL] [Abstract][Full Text] [Related]
2. Hyaluronan Nanoparticles Selectively Target Plaque-Associated Macrophages and Improve Plaque Stability in Atherosclerosis. Beldman TJ; Senders ML; Alaarg A; Pérez-Medina C; Tang J; Zhao Y; Fay F; Deichmöller J; Born B; Desclos E; van der Wel NN; Hoebe RA; Kohen F; Kartvelishvily E; Neeman M; Reiner T; Calcagno C; Fayad ZA; de Winther MPJ; Lutgens E; Mulder WJM; Kluza E ACS Nano; 2017 Jun; 11(6):5785-5799. PubMed ID: 28463501 [TBL] [Abstract][Full Text] [Related]
3. Endothelial deficiency of insulin-like growth factor-1 receptor reduces endothelial barrier function and promotes atherosclerosis in Higashi Y; Sukhanov S; Shai SY; Danchuk S; Snarski P; Li Z; Hou X; Hamblin MH; Woods TC; Wang M; Wang D; Yu H; Korthuis RJ; Yoshida T; Delafontaine P Am J Physiol Heart Circ Physiol; 2020 Oct; 319(4):H730-H743. PubMed ID: 32795184 [TBL] [Abstract][Full Text] [Related]
4. Partial Inhibition of Glycolysis Reduces Atherogenesis Independent of Intraplaque Neovascularization in Mice. Perrotta P; Van der Veken B; Van Der Veken P; Pintelon I; Roosens L; Adriaenssens E; Timmerman V; Guns PJ; De Meyer GRY; Martinet W Arterioscler Thromb Vasc Biol; 2020 May; 40(5):1168-1181. PubMed ID: 32188275 [TBL] [Abstract][Full Text] [Related]
5. Nanotherapeutic Shots through the Heart of Plaque. Kanthi Y; de la Zerda A; Smith BR ACS Nano; 2020 Feb; 14(2):1236-1242. PubMed ID: 31986012 [TBL] [Abstract][Full Text] [Related]
6. Diverse ultrastructural landscape of atherosclerotic endothelium. Kluza E; Beldman TJ; Shami A; Scholl ER; Malinova TS; Grootemaat AE; van der Wel NN; Gonçalves I; Huveneers S; Mulder WJM; Lutgens E Atherosclerosis; 2021 Dec; 339():35-45. PubMed ID: 34847419 [TBL] [Abstract][Full Text] [Related]
7. Anti-JNK2 peptide-siRNA nanostructures improve plaque endothelium and reduce thrombotic risk in atherosclerotic mice. Pan H; Palekar RU; Hou KK; Bacon J; Yan H; Springer LE; Akk A; Yang L; Miller MJ; Pham CT; Schlesinger PH; Wickline SA Int J Nanomedicine; 2018; 13():5187-5205. PubMed ID: 30233180 [TBL] [Abstract][Full Text] [Related]
8. Effective atherosclerotic plaque inflammation inhibition with targeted drug delivery by hyaluronan conjugated atorvastatin nanoparticles. Hossaini Nasr S; Rashidijahanabad Z; Ramadan S; Kauffman N; Parameswaran N; Zinn KR; Qian C; Arora R; Agnew D; Huang X Nanoscale; 2020 May; 12(17):9541-9556. PubMed ID: 32314997 [TBL] [Abstract][Full Text] [Related]
9. Role of endothelial cell-derived angptl2 in vascular inflammation leading to endothelial dysfunction and atherosclerosis progression. Horio E; Kadomatsu T; Miyata K; Arai Y; Hosokawa K; Doi Y; Ninomiya T; Horiguchi H; Endo M; Tabata M; Tazume H; Tian Z; Takahashi O; Terada K; Takeya M; Hao H; Hirose N; Minami T; Suda T; Kiyohara Y; Ogawa H; Kaikita K; Oike Y Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):790-800. PubMed ID: 24526691 [TBL] [Abstract][Full Text] [Related]
10. Quantifying the evolution of vascular barrier disruption in advanced atherosclerosis with semipermeant nanoparticle contrast agents. Zhang H; Zhang L; Myerson J; Bibee K; Scott M; Allen J; Sicard G; Lanza G; Wickline S PLoS One; 2011; 6(10):e26385. PubMed ID: 22028868 [TBL] [Abstract][Full Text] [Related]
11. Plaque-hyaluronidase-responsive high-density-lipoprotein-mimetic nanoparticles for multistage intimal-macrophage-targeted drug delivery and enhanced anti-atherosclerotic therapy. Zhang M; He J; Jiang C; Zhang W; Yang Y; Wang Z; Liu J Int J Nanomedicine; 2017; 12():533-558. PubMed ID: 28144137 [TBL] [Abstract][Full Text] [Related]
12. Irisin protects against endothelial injury and ameliorates atherosclerosis in apolipoprotein E-Null diabetic mice. Lu J; Xiang G; Liu M; Mei W; Xiang L; Dong J Atherosclerosis; 2015 Dec; 243(2):438-48. PubMed ID: 26520898 [TBL] [Abstract][Full Text] [Related]
13. Targeted therapy of atherosclerosis by pH-sensitive hyaluronic acid nanoparticles co-delivering all-trans retinal and rapamycin. Cheraga N; Ye Z; Xu MJ; Zou L; Sun NC; Hang Y; Shan CJ; Yang ZZ; Chen LJ; Huang NP Nanoscale; 2022 Jun; 14(24):8709-8726. PubMed ID: 35673987 [TBL] [Abstract][Full Text] [Related]
14. Nucleophosmin contributes to vascular inflammation and endothelial dysfunction in atherosclerosis progression. Rao C; Liu B; Huang D; Chen R; Huang K; Li F; Dong N J Thorac Cardiovasc Surg; 2021 May; 161(5):e377-e393. PubMed ID: 32007256 [TBL] [Abstract][Full Text] [Related]
15. Targeted delivery of protein arginine deiminase-4 inhibitors to limit arterial intimal NETosis and preserve endothelial integrity. Molinaro R; Yu M; Sausen G; Bichsel CA; Corbo C; Folco EJ; Lee GY; Liu Y; Tesmenitsky Y; Shvartz E; Sukhova GK; Kloss F; Croce KJ; Farokhzad OC; Shi J; Libby P Cardiovasc Res; 2021 Nov; 117(13):2652-2663. PubMed ID: 33751034 [TBL] [Abstract][Full Text] [Related]
16. Pioglitazone-Incorporated Nanoparticles Prevent Plaque Destabilization and Rupture by Regulating Monocyte/Macrophage Differentiation in ApoE-/- Mice. Nakashiro S; Matoba T; Umezu R; Koga J; Tokutome M; Katsuki S; Nakano K; Sunagawa K; Egashira K Arterioscler Thromb Vasc Biol; 2016 Mar; 36(3):491-500. PubMed ID: 26821947 [TBL] [Abstract][Full Text] [Related]
17. CXCR4-Binding Positron Emission Tomography Tracers Link Monocyte Recruitment and Endothelial Injury in Murine Atherosclerosis. Baba O; Huang LH; Elvington A; Szpakowska M; Sultan D; Heo GS; Zhang X; Luehmann H; Detering L; Chevigne A; Liu Y; Randolph GJ Arterioscler Thromb Vasc Biol; 2021 Feb; 41(2):822-836. PubMed ID: 33327748 [TBL] [Abstract][Full Text] [Related]
18. Nanoparticles targeting extra domain B of fibronectin-specific to the atherosclerotic lesion types III, IV, and V-enhance plaque detection and cargo delivery. Yu M; Ortega CA; Si K; Molinaro R; Schoen FJ; Leitao RFC; Xu X; Mahmoudi M; Ahn S; Liu J; Saw PE; Lee IH; Brayner MMB; Lotfi A; Shi J; Libby P; Jon S; Farokhzad OC Theranostics; 2018; 8(21):6008-6024. PubMed ID: 30613278 [TBL] [Abstract][Full Text] [Related]
19. Hyaluronic acid nanoparticles for active targeting atherosclerosis. Lee GY; Kim JH; Choi KY; Yoon HY; Kim K; Kwon IC; Choi K; Lee BH; Park JH; Kim IS Biomaterials; 2015; 53():341-8. PubMed ID: 25890732 [TBL] [Abstract][Full Text] [Related]
20. Exogenous Insulin Infusion Can Decrease Atherosclerosis in Diabetic Rodents by Improving Lipids, Inflammation, and Endothelial Function. Park K; Li Q; Evcimen ND; Rask-Madsen C; Maeda Y; Maddaloni E; Yokomizo H; Shinjo T; St-Louis R; Fu J; Gordin D; Khamaisi M; Pober D; Keenan H; King GL Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):92-101. PubMed ID: 29162603 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]